Clinical Effects of Sivelestat Sodium on Improving ARDS in Patients With COVID-19
NCT06218862
·
clinicaltrials.gov ↗
COMPLETED
Status
387
Enrollment
OTHER
Sponsor class
Conditions
ARDS Due to Disease Caused by SARS Co-V-2
Interventions
DRUG:
Sivelestat sodium
DRUG:
Control
Sponsor
The First Hospital of Jilin University